ASCO17

News

Chicago, IL - 2017 ASCO Annual Meeting - Attendees and poster presenters during Posters Sessions at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday June 3, 2017. Over 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 53rd Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epidemiological studies. Photo by © ASCO/David Eulitt 2017 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org

High cost of cancer drugs takes centre stage at ASCO

The cost of cancer drugs became a major talking point at this year’s ASCO conference, where doctors raised concerns about the “financial toxicity” patients face in paying for very expensive

News

Puma gains as Roche breast cancer combo disappoints

ASCO serves up shock as Roche's data disappoints

News

ASCO round up: Zytiga shines in frontline prostate role, Lox...

While ASCO often showcases the benefits of new cancer therapies, it was a well-established drug that proved to be a talking point at this year’s conference in Chicago.

News

Lynparza first PARP drug to show promise in breast cancer

Data sets AZ up to file Lynparza in new indication

News

Novartis' Basel HQ: the company is looking for more blockbusters to lift revenues

Spectacular early results for Novartis’ CAR-T combined with ...

A combination of Novartis’ 'next generation' CAR-T drug CTL119 with Janssen and AbbVie's Imbruvica has cleared all signs of chronic lymphocytic leukaemia from eight out of nine patients in

News